Establishment Labs stock (VGG3006U1060): Analyst optimism follows recent trading update

Establishment Labs is back on the radar for US investors after recent market data showed the Nasdaq-listed stock at $65.55 on May 19, 2026, with extended trading near $65.52, according to MarketBeat as of 05/19/2026. The move matters because the company sits in a niche of the global medical aesthetics market that is closely tied to elective procedure demand in the US and abroad.

At the same time, recent analyst coverage tracked by MarketBeat shows an average twelve-month target of $87.14 across eight analysts, with the high estimate at $100.00 and the low at $74.00, according to MarketBeat as of 05/21/2026. That does not tell investors where the stock will go next, but it does explain why the name remains active on watchlists in the US market.